Hybridon HYBN, for discussion of antisense drugs. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hybridon HYBN, for discussion of antisense drugs.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mike head who wrote (28)	7/22/1998 10:29:00 PM
From: JMarcus	of 42

An Advisory Panel recommends approval of ISIP's antisense drug today and HYBN's stock rises 38.46%. Just a coincidence? I don't think so. Trading in ISIP's shares was suspended today because of the AP meeting, but in afterhours trading the stock is shooting skyward. I am expecting sympathy rises in the other antisense companies' stock tomorrow once the significance of this news (the first vindication of a significant antisense drug) begins to sink in. Go HYBN!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next